| Product Name | MF | CAS | Details |
|---|
| 2-Amino-8-hydroxypurine-9-beta-D-(2’,5’-di-O-acetyl-3’-deoxy)riboside | C14H17N5O6 | 2389988-74-1 | Details |
| 1-PeCSO | C6H11NO3S | 3836-24-6 | Details |
| CP-96021 hydrochloride | C29H22ClFN4OS | 167011-22-5 | Details |
| Galidesivir triphosphate | C11H18N5O12P3 | 1467740-78-8 | Details |
| BMT-124110 | C21H27N3O3 | 1679371-59-5 | Details |
| ERRγ Inverse Agonist 1 | C30H37ClN2O2 | 2316832-86-5 | Details |
| Tepotinib hydrochloride(1 : x) | C29H29ClN6O2 | 1103508-80-0 | Details |
| 10NH2-11F-Camptothecin | C20H16FN3O4 | 2873460-30-9 | Details |
| 20-HETE inhibitor-1 | C19H24N4O | 2472030-28-5 | Details |
| Rifamycin S | C37H45NO12 | 13553-79-2 | Details |
| ASP1126 | C26H26ClF6NO5 | 1228580-11-7 | Details |
| c-Fms-IN-7 | C26H24N6OS | 1313408-89-7 | Details |
| DC4SMe | C35H31ClN5O7PS2 | 615538-47-1 | Details |
| N-Fmoc-aminohexyl P-methyl phosphonamidite | C28H41N2O3P | 128745-89-1 | Details |
| 3’-Azido-3’-deoxyinosine | C10H11N7O4 | 946497-27-4 | Details |
| Antitrypanosomal agent 2 | C17H13N5O3 | 475626-30-3 | Details |
| Cardiotoxin Analog (CTX) IV (6-12) TFA | C48H70N10O7.C2HF3O2 | 2918768-05-3 | Details |
| DS08210767 | C31H39N5O2 | 2376334-75-5 | Details |
| Aβ42-IN-1 free base | C29H26N4O2 | 2434633-17-5 | Details |
| 2’-O-Phthalimidopropyl cytidine | C20H22N4O7 | 165381-50-0 | Details |
| 1-[3’-O-[(4,4’-dimethoxytriphenyl)methyl]-a-L-threofuranosyl]-N6-benzoyladenine | C37H33N5O6 | 325683-88-3 | Details |
| 1-alpha-D-(3-Meth oxynaphthalen-2-yl)-2’-deoxy riboside; (1S)-1,4-Anhy dro-2-deoxy-1-C-(3-methoxy)-naphthalenyl)-D-erythro-pentitol | C16H18O4 | 1502811-53-1 | Details |
| 7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy guanosine | C13H15N5O5 | 2389988-54-7 | Details |
| 2’-O-(2-Cyanoethoxy) ? (diisopropylamino)phosphino-3’-O-(4,4’-dimethoxy triphenyl)methyl-N2-isobutyryl-(R)-9-(2,3-dihydroxypropyl)-guanine | C42H52N7O7P | 182625-78-1 | Details |
| RR-src acetate | C64H106N22O21.C2H4O2 | 2986315-28-8 | Details |
| 5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole | C15H16BrN3O2 | 2863687-18-5 | Details |
| 5’-Deoxy-5’-N-methylaminothymidine | Details |
| BAY-7598 | C28H31N3O6 | 1816257-74-5 | Details |
| Loteprednol Etabonate-d5 | C24H31ClO7 | 2026643-11-6 | Details |
| Antitumor agent-19 | C24H21ClF3N5O | 2379727-90-7 | Details |
| 5-Aza-3’-deoxycytidine | C8H12N4O4 | 455951-65-2 | Details |
| 2’-O-Phthalimidopropyl uridine | C20H21N3O8 | 165381-44-2 | Details |
| CP5V | C46H66Cl3N9O12S | 2509359-75-3 | Details |
| (αR)-Cyclopropaneacetamide-Exatecan | C29H28FN3O6 | 2414254-37-6 | Details |
| (S)-9-(2,3-Dihydroxypropyl)-2-amino-6-chloropurine | C8H10ClN5O2 | 885322-01-0 | Details |
| Compound 2389988-36-5 | C14H17N5O8 | 2389988-36-5 | Details |
| 5'-homocytidine | C10H15N3O5 | 55085-34-2 | Details |
| BPH-1358 free base | C32H28N6O2 | 801985-13-7 | Details |
| CD235 | C26H20FN5O2 | 1627716-57-7 | Details |
| anti-TB agent 1 | C23H19F3N4O3 | 2294013-78-6 | Details |
| Cdc7-IN-3 | C20H22N4O5 | 1402057-87-7 | Details |
| D-Cl-amidine | C14H19ClN4O2 | 1404060-15-6 | Details |
| Dopamine D2 receptor antagonist-1 | C14H17N3S | 1055411-77-2 | Details |
| Flibanserin-d4 | C20H21F3N4O | 2122830-90-2 | Details |
| Chitinase-IN-2 hydrochloride | C20H22ClN5O2S | 2070014-83-2 | Details |
| 7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro-xylo-guanosine | C13H14FN5O5 | 2389988-56-9 | Details |
| 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-2,5-di-O-acetyl-3-deoxy-3-fluoro-ribofuranosyl)purine | C17H18FN5O6 | 2389986-90-5 | Details |
| (1R)-Deruxtecan | C52H56FN9O13 | 2270986-87-1 | Details |
| GSK778 hydrochloride | C30H33N5O3.ClH | 2863657-79-6 | Details |
| (1-OH)-Exatecan | 2894780-53-9 | Details |
| (R)-FT709 | C23H22N4O7S | 2413991-75-8 | Details |
| 2-C-methylene-myo-inositol oxide | C7H12O6 | 4068-87-5 | Details |
| 1-[(5E)-5,6-Dideoxy-6-(diethoxyphosphinyl)-2-O-(2-methoxy ethyl)-β-D-ribo-hex-5-enofuranosyl]-5-methyluracil | C18H29N2O9P | 1345562-43-7 | Details |
| BY27 | C22H21ClN6 | 2247236-59-3 | Details |
| Autotaxin-IN-5 | C30H29N9O2 | 2156655-99-9 | Details |
| AHR antagonist 4 | C20H14F6N4O4 | 2242465-58-1 | Details |
| 2’-Deoxy-2’-fluoro-5-methyl-araobinocytidine ?5’-triphosphate triethyl ammonium salt（79570-62-0 free base) | C10H17FN3O13P3 | 79570-62-0 | Details |
| 1,2-Di-O-acetyl-3,5-di-O-benzyl-D-xylofuranose | C23H26O7 | 146986-45-0 | Details |
| gamma-secretase modulator 1 hydrochloride | C24H25ClN4OS | 2741571-83-3 | Details |
| Compound 2389988-38-7 | C14H17N5O7 | 2389988-38-7 | Details |
| 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-3-deoxy-ribofuranosyl)purine | C13H15N5O4 | 2389988-75-2 | Details |
| 7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro guanosine | C13H14FN5O5 | 2389988-55-8 | Details |
| 2-Acetylamino-1-{3’-O-[(4,4’-dimethoxy triphenyl)methyl]-a-L-threo furanosyl}-6-(N,N-diphenylcarbamoyloxy)-9H-purine | C45H40N6O8 | 325683-92-9 | Details |
| 2-Amino-7-cyclopropyl methyl-7,8-dihydro-8-oxo-9-(beta-D-xylo furanosyl)purine | C14H19N5O5 | 2389988-30-9 | Details |
| N2,N2-Dimethylamino-6-deamino adenosine | C12H17N5O4 | 105208-35-3 | Details |
| H-PRO-HIS-CYS-LYS-ARG-MET-OH acetate | C31H54N12O7S2.C2H4O2 | 2918771-43-2 | Details |
| 2-Amino -7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-2,3,5-tri-O-actyl-xylofuranosyl)purine | C19H21N5O8 | 2389988-52-5 | Details |
| N4-Benzoyl-1-(6-O-DMTr-2,3-dideoxy-beta-D-erythro-hexopyranosyl)cytosine | C38H37N3O7 | 145594-00-9 | Details |
| 2-Quinizarincarboxylic acid | C15H8O6 | 6416-55-3 | Details |
| Autotaxin-IN-4 | C22H21N9O2 | 2156655-86-4 | Details |
| Antitumor agent-2 | C33H42N4O4 | 1351163-57-9 | Details |
| BI-1408 | C22H23FN6 | 2231075-94-6 | Details |
| 8-Benzyloxy-9-(b-D-xylofuranosyl)guanine | C17H19N5O6 | 2389988-19-4 | Details |
| Lys-Bradykinin acetate(342-10-9 free base) | C56H85N17O12.4C2H4O2 | 84640-50-6 | Details |
| Patamostat HCl | C20H20N4O4S.ClH | 3031765-17-7 | Details |
| (S)-(-)-MRJF22 | 2757301-90-7 | Details |
| (E)-5-Octadecene | C18H36 | 7206-21-5 | Details |
| 2R-[(4,4’-Dimethoxy trityloxy)methyl]oxirane | C24H24O4 | 171406-50-1 | Details |
| Cdc7-IN-4 | C22H24F3N5O4 | 1402059-21-5 | Details |
| CYT-1010 hydrochloride | C35H41ClN6O5 | 1161517-81-2 | Details |
| Aniline-MPB-amino-C3-PBD | C42H46N8O6 | 2412923-79-4 | Details |
| 3’-O-Acetyl-2’-deoxyuridine | C11 H14 N2 O6 | 23197-88-8 | Details |
| Alpha-5-Methyluridine | C10H14N2O6 | 3258-09-1 | Details |
| 1-(2,3-Dideoxy-2,3-didehydro-a-D-erythro-hexo pyranosyl) cytosine | C10H13N3O4 | 199599-71-8 | Details |
| 5-(2-Hydroxyethyl)cytidine | C11H17N3O6 | 137248-64-7 | Details |
| TRV-120027 acetate (1234510-46-3 free base) | C45H71N13O12 | 1824712-70-0 | Details |
| BET-IN-6 | C22H20N2O6S | 2570470-39-0 | Details |
| AR453588 hydrochloride | C25H26ClN7O2S2 | 1065606-97-4 | Details |
| Methyl ? 3’-O-benzyl xyloriboside | C13H18O5 | 201014-45-1 | Details |
| TLR7 agonist 13 | C17H19N5O6 | 2389988-70-7 | Details |
| 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)purine | C13H15N5O5 | 2389988-53-6 | Details |
| 1-Palmitoyl-2-succinyl-sn-glycerophosphorylcholine | C28H54NO10P | 89947-80-8 | Details |
| (2E,9Z)-Octadeca-2,9-dienoic acid | C18H32O2 | 182369-03-5 | Details |
| (R)-Monlunabant | 2765579-76-6 | Details |
| Milnacipran-d5 HCl | C15H17D5N2O.ClH | 2750534-79-1 | Details |
| BSc5371 | C24H31N5O4S | 2286419-03-0 | Details |
| GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
| Antifungal agent 2 | C19H11Br2F3N4O2 | 2211060-61-4 | Details |
| CMLD012073 | C30H30N2O7 | 2368900-32-5 | Details |
| DC-5163 | C18H20ClN3OS | 897771-47-0 | Details |
| Product Total： Product Page： | ||||
| 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 | ||||